Clinical Trials Directory

Trials / Completed

CompletedNCT02865837

Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer

Effect of Bladder Distension on Organs at Risk Doses in PDR 3D Image-guided Brachytherapy of Cervical Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Institut de Cancérologie de Lorraine · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare, for each patient, dosimetry of organs at risk (bladder, rectum, sigmoid, small bowel) in two bladder distension procedures (emptied by a urinary catheter or filled with 120cc) during PDR 3D image-guided brachytherapy of cervical cancer.

Conditions

Interventions

TypeNameDescription
OTHERbrachytherapyThe brachytherapy applicator and a urinary catheter are set up in the operating room under general anesthesia. Then, an MRI (or a scanner if contra-indication) is performed after a bladder filling with 120cc of normal saline solution and urinary catheter clamping. Right after, a scanner is performed with urinary catheter declamping and emptied bladder. Delineation of CTVs and organs at risk (bladder, rectum, sigmoid, small bowel), and dosimetric optimisation are made on study with filled bladder. Then, organs at risk are delineated on the study with emptied bladder. The prior dosimetry is reset on this study and organs at risk doses are compared.

Timeline

Start date
2015-09-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2016-08-15
Last updated
2026-03-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02865837. Inclusion in this directory is not an endorsement.

Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer (NCT02865837) · Clinical Trials Directory